Advertisement
U.S. markets closed
  • S&P 500

    5,137.08
    +40.81 (+0.80%)
     
  • Dow 30

    39,087.38
    +90.99 (+0.23%)
     
  • Nasdaq

    16,274.94
    +183.02 (+1.14%)
     
  • Russell 2000

    2,076.39
    +21.55 (+1.05%)
     
  • Crude Oil

    79.81
    +1.55 (+1.98%)
     
  • Gold

    2,091.60
    +36.90 (+1.80%)
     
  • Silver

    23.34
    +0.46 (+2.01%)
     
  • EUR/USD

    1.0839
    +0.0032 (+0.29%)
     
  • 10-Yr Bond

    4.1800
    -0.0720 (-1.69%)
     
  • GBP/USD

    1.2655
    +0.0029 (+0.23%)
     
  • USD/JPY

    150.0640
    +0.0800 (+0.05%)
     
  • Bitcoin USD

    61,816.25
    -362.22 (-0.58%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,682.50
    +52.48 (+0.69%)
     
  • Nikkei 225

    39,910.82
    +744.63 (+1.90%)
     

Amarin (AMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Amarin (AMRN) reported $66.06 million in revenue for the quarter ended September 2023, representing a year-over-year decline of 26.5%. EPS of $0.00 for the same period compares to $0.02 a year ago.

The reported revenue represents a surprise of +14.77% over the Zacks Consensus Estimate of $57.56 million. With the consensus EPS estimate being -$0.02, the EPS surprise was +100.00%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Amarin performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Product Revenue - Europe: $0.80 million versus the two-analyst average estimate of $0.83 million.

  • Product Revenue - US: $62.40 million compared to the $52.77 million average estimate based on two analysts.

  • Product revenues: $64.90 million versus the three-analyst average estimate of $55.43 million. The reported number represents a year-over-year change of -27.3%.

  • Licensing revenue: $1.15 million compared to the $1.99 million average estimate based on three analysts. The reported number represents a change of +75.8% year over year.

View all Key Company Metrics for Amarin here>>>

Shares of Amarin have returned -18.5% over the past month versus the Zacks S&P 500 composite's -2.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Amarin Corporation PLC (AMRN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Advertisement